Grace Kim joins Rentschler Biopharma US team Grace Kim joins Rentschler Biopharma US team Kim has taken the VP Business Development role, strengthening the US presence of the German CDMO TrakCel co-founder takes the wheel TrakCel co-founder takes the wheel Co-founder Dr Fiona Withey has been named as CEO of TrakCel and fellow co-founder Ravi Nalliah as Chief Strategy Officer DuPont replaces CEO after falling short of 2019 expectations DuPont replaces CEO after falling short of 2019 expectations Ex-CEO and executive Chairman Edward Breen has taken back the CEO role at DuPont CPI CEO passes the torch CPI CEO passes the torch Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar Applied Photophysics makes key appointments Applied Photophysics makes key appointments Tim Flanagan has taken the CEO role and Marc Neglia has been promoted to President of Applied Photophysics Inc. Pathios Therapeutics chooses founding member of Scientific Advisory Board Pathios Therapeutics chooses founding member of Scientific Advisory Board Dr Tobias Bopp has been chosen to be the first member of the cancer and autoimmune–focused biotech’s Scientific Advisory Board Rentschler Biopharma hires new VP for North America and APAC Rentschler Biopharma hires new VP for North America and APAC Grace Kim has joined Germany-based CDMO as VP of Business Development for North America and APAC Former Exyte executive joins BPE Former Exyte executive joins BPE Mark Rowland to lead business development at the UK biochemical engineering design company Enterprise Therapeutics appoints new Chief Medical Officer Enterprise Therapeutics appoints new Chief Medical Officer Dr Davis Morris has been appointed to lead Enteprise’s development strategy and drive its two lead respiratory programmes through the clinic Verona Pharma gets new CEO and COO Verona Pharma gets new CEO and COO Respiratory-focused biopharma has appointed David Zaccardelli as President and CEO, and Mark Hahn as COO NSF International EVP joins regulatory board NSF International EVP joins regulatory board The Regulatory Affairs Professionals Society (RAPS) has appointed Kim Trautman to its board of directors Syntegon Technology names new CEO Syntegon Technology names new CEO Dr Michael Grosse has been chosen as the new CEO of Syntegon shortly after changing its name from Bosch Packaging Technology New management team at Evolva to deliver strategic priorities New management team at Evolva to deliver strategic priorities Former Lonza CEO has been proposed to join the Swiss biotech and ingredients company PhoreMost fills Director roles with an OBE and a PhD PhoreMost fills Director roles with an OBE and a PhD UK biopharma has appointed Dr Beech as a Non-Executive Director and Dr Cross as Senior Director of Technology Clasado CEO Per Rehné joins Global Prebiotic Association’s Communications Committee Clasado CEO Per Rehné joins Global Prebiotic Association’s Communications Committee Rehné will work to establish a proactive, objective voice on issues of importance to the prebiotic community Matthew Durdy to spearhead CGT Catapult Matthew Durdy to spearhead CGT Catapult Durdy will take up the role of Chief Executive Officer in April this year ACG Group names new Chief Marketing Officer ACG Group names new Chief Marketing Officer Alexander Robinson has been chosen to replace Peter Neve at Head office in Mumbai, as his predecessor returns to his home country FDA swears in Dr Stephen Hahn as new Commissioner FDA swears in Dr Stephen Hahn as new Commissioner Oncolgy specilalist Dr Stephen Hahn has started his new position as leader of the US regulatory body Former Celgene CEO joins board of Chinese-US joint venture Former Celgene CEO joins board of Chinese-US joint venture The Antengene board has appointed Mark Alles as an independent director of the company Avacta Group appoints new Non-Executive Director Avacta Group appoints new Non-Executive Director Paul Fry has been appointed to the senior role and will begin in February Catalent strengthens biologics business with key senior appointments Catalent strengthens biologics business with key senior appointments Karen Flynn has been appointed President of Biologics and Chief Commercial Officer alongside two other regional biologic Presidents Abcam announces new Chief Financial Officer Abcam announces new Chief Financial Officer Michael Baldock to take on the role as Gavin Wood will step down on 3 February 2020 Nanoform appoints Head of US Sales Nanoform appoints Head of US Sales Clasado boosts product development with key appointment Clasado boosts product development with key appointment Dr Lucien Harthoorn has taken the role of Research & Development Director to oversee developments at the prebiotic ingredients company